CID 169501793

Sildenafil metabolite m11

Structural Information

Molecular Formula
C21H28N6O5S
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)O)OCC)C
InChI
InChI=1S/C21H28N6O5S/c1-4-6-16-18-19(25(3)24-16)21(28)23-20(22-18)15-13-14(7-8-17(15)32-5-2)33(30,31)27-11-9-26(29)10-12-27/h7-8,13,29H,4-6,9-12H2,1-3H3,(H,22,23,28)
InChIKey
AYLUSVSOHVNHCJ-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-(4-hydroxypiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

476.1842 Da
Monoisotopic Mass

1.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 477.19148 216.4
[M+Na]+ 499.17342 225.7
[M-H]- 475.17692 217.9
[M+NH4]+ 494.21802 218.4
[M+K]+ 515.14736 218.1
[M+H-H2O]+ 459.18146 206.7
[M+HCOO]- 521.18240 221.2
[M+CH3COO]- 535.19805 230.5
[M+Na-2H]- 497.15887 214.6
[M]+ 476.18365 220.5
[M]- 476.18475 220.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.